CB1 Capital Management predicts Cannabis could disrupt the healthcare industry in a big way. The firm's Founding Partner and Chief Investment Officer Todd Harrison explains why he thinks medical marijuana will migrate from state dispensaries, to become medicine prescribed by doctors through insurance in the next decade.
Harrison says the only way the U.S. government would get their hands on the money in this market opportunity is through the FDA. "That's where we think it goes, follow the money," says Harrison.
"This is not so much a trade about commerce, as it is a trade about healthcare," said Harrison. "We think that this is going to migrate towards medicine." One of CB1 Capital Management's holdings GW Pharmaceuticals is up 30 percent over the past three months. Harrison expects this company to publish research showing the efficacy of cannabis treatment this summer.
The Verge's Emma Roth joins Cheddar to discuss the iPhone 16, Apple Watch upgrades, all things Airpods and Apple Intelligence. But is it worth the hype? Watch!
The U.S. added 142,000 jobs in August, below expectations. The unemployment rate fell to 4.2%. The cooling job market raises chances for an interest rate cut.
The X and Starlink owner plays a game of chicken with Brazil's Supreme Court. Also: Disney v DirecTV, the future of steel, and that crazy ol' stock market!
Find out what Gen Z is saying about how money equates to happiness from Voya Financial and what they think they need to start saving for retirement. Watch!
